189 related articles for article (PubMed ID: 8786724)
1. Effect of L-thyroxine therapy on lipoprotein fractions in overt and subclinical hypothyroidism, with special reference to lipoprotein(a).
Arem R; Escalante DA; Arem N; Morrisett JD; Patsch W
Metabolism; 1995 Dec; 44(12):1559-63. PubMed ID: 8786724
[TBL] [Abstract][Full Text] [Related]
2. Lipid profile in subclinical hypothyroidism: is L-thyroxine substitution beneficial?
Efstathiadou Z; Bitsis S; Milionis HJ; Kukuvitis A; Bairaktari ET; Elisaf MS; Tsatsoulis A
Eur J Endocrinol; 2001 Dec; 145(6):705-10. PubMed ID: 11720894
[TBL] [Abstract][Full Text] [Related]
3. Lipoprotein(a) concentration in subclinical hypothyroidism before and after levo-thyroxine therapy.
Yildirimkaya M; Ozata M; Yilmaz K; Kilinç C; Gündoğan MA; Kutluay T
Endocr J; 1996 Dec; 43(6):731-6. PubMed ID: 9075615
[TBL] [Abstract][Full Text] [Related]
4. Lipoprotein(a) and other lipoproteins in hypothyroid patients before and after thyroid replacement therapy.
Becerra A; Bellido D; Luengo A; Piédrola G; De Luis DA
Clin Nutr; 1999 Oct; 18(5):319-22. PubMed ID: 10601541
[TBL] [Abstract][Full Text] [Related]
5. Changes in lipoprotein(a) levels in overt and subclinical hypothyroidism before and during treatment.
Tzotzas T; Krassas GE; Konstantinidis T; Bougoulia M
Thyroid; 2000 Sep; 10(9):803-8. PubMed ID: 11041458
[TBL] [Abstract][Full Text] [Related]
6. TSH-controlled L-thyroxine therapy reduces cholesterol levels and clinical symptoms in subclinical hypothyroidism: a double blind, placebo-controlled trial (Basel Thyroid Study).
Meier C; Staub JJ; Roth CB; Guglielmetti M; Kunz M; Miserez AR; Drewe J; Huber P; Herzog R; Müller B
J Clin Endocrinol Metab; 2001 Oct; 86(10):4860-6. PubMed ID: 11600554
[TBL] [Abstract][Full Text] [Related]
7. Effect of levo-thyroxine replacement on non-high-density lipoprotein cholesterol in hypothyroid patients.
Ito M; Arishima T; Kudo T; Nishihara E; Ohye H; Kubota S; Fukata S; Amino N; Kuma K; Sasaki I; Hiraiwa T; Hanafusa T; Takamatsu J; Miyauchi A
J Clin Endocrinol Metab; 2007 Feb; 92(2):608-11. PubMed ID: 17148561
[TBL] [Abstract][Full Text] [Related]
8. Lipoprotein and apolipoprotein levels in subclinical hypothyroidism. Effect of levothyroxine therapy.
Arem R; Patsch W
Arch Intern Med; 1990 Oct; 150(10):2097-100. PubMed ID: 2222095
[TBL] [Abstract][Full Text] [Related]
9. Age and gender substantially influence the relationship between thyroid status and the lipoprotein profile: results from a large cross-sectional study.
Tognini S; Polini A; Pasqualetti G; Ursino S; Caraccio N; Ferdeghini M; Monzani F
Thyroid; 2012 Nov; 22(11):1096-103. PubMed ID: 23050788
[TBL] [Abstract][Full Text] [Related]
10. Elevated serum lipoprotein(a) in subclinical hypothyroidism.
Kung AW; Pang RW; Janus ED
Clin Endocrinol (Oxf); 1995 Oct; 43(4):445-9. PubMed ID: 7586619
[TBL] [Abstract][Full Text] [Related]
11. Long-term thyroid replacement therapy and levels of lipoprotein(a) and other lipoproteins.
Pazos F; Alvarez JJ; Rubiés-Prat J; Varela C; Lasunción MA
J Clin Endocrinol Metab; 1995 Feb; 80(2):562-6. PubMed ID: 7852521
[TBL] [Abstract][Full Text] [Related]
12. Serum lipid levels in relation to serum thyroid-stimulating hormone and the effect of thyroxine treatment on serum lipid levels in subjects with subclinical hypothyroidism: the Tromsø Study.
Iqbal A; Jorde R; Figenschau Y
J Intern Med; 2006 Jul; 260(1):53-61. PubMed ID: 16789979
[TBL] [Abstract][Full Text] [Related]
13. Increased oxidizability of low-density lipoproteins in hypothyroidism.
Diekman T; Demacker PN; Kastelein JJ; Stalenhoef AF; Wiersinga WM
J Clin Endocrinol Metab; 1998 May; 83(5):1752-5. PubMed ID: 9589687
[TBL] [Abstract][Full Text] [Related]
14. Spectrum of subclinical and overt hypothyroidism: effect on thyrotropin, prolactin, and thyroid reserve, and metabolic impact on peripheral target tissues.
Staub JJ; Althaus BU; Engler H; Ryff AS; Trabucco P; Marquardt K; Burckhardt D; Girard J; Weintraub BD
Am J Med; 1992 Jun; 92(6):631-42. PubMed ID: 1605145
[TBL] [Abstract][Full Text] [Related]
15. Dyslipoproteinaemia in hypothyroidism of pituitary origin: effects of L-thyroxine substitution on lipoprotein lipase, hepatic lipase, and on plasma lipoproteins.
Valdemarsson S; Hedner P; Nilsson-Ehle P
Acta Endocrinol (Copenh); 1983 Jun; 103(2):192-7. PubMed ID: 6858552
[TBL] [Abstract][Full Text] [Related]
16. Lipoprotein (a) levels and apolipoprotein (a) isoform size in patients with subclinical hypothyroidism: effect of treatment with levothyroxine.
Milionis HJ; Efstathiadou Z; Tselepis AD; Bairaktari ET; Tsironis LD; Tsatsoulis A; Elisaf MS
Thyroid; 2003 Apr; 13(4):365-9. PubMed ID: 12804105
[TBL] [Abstract][Full Text] [Related]
17. Plasma levels of lipoproteins and apolipoproteins in congenital hypothyroidism: effects of L-thyroxine substitution therapy.
Barbagallo CM; Averna MR; Liotta A; La Grutta S; Maggio C; Casimiro L; Cefalù AB; Notarbartolo A
Metabolism; 1995 Oct; 44(10):1283-7. PubMed ID: 7476285
[TBL] [Abstract][Full Text] [Related]
18. Effect of L-thyroxine replacement on apolipoprotein B-48 in overt and subclinical hypothyroid patients.
Ito M; Kitanaka A; Arishima T; Kudo T; Nishihara E; Kubota S; Amino N; Hiraiwa T; Hanafusa T; Miyauchi A
Endocr J; 2013; 60(1):65-71. PubMed ID: 22986485
[TBL] [Abstract][Full Text] [Related]
19. Lipoprotein(a) and apolipoprotein B plasma concentrations in hypothyroid, euthyroid, and hyperthyroid subjects.
de Bruin TW; van Barlingen H; van Linde-Sibenius Trip M; van Vuurst de Vries AR; Akveld MJ; Erkelens DW
J Clin Endocrinol Metab; 1993 Jan; 76(1):121-6. PubMed ID: 8421075
[TBL] [Abstract][Full Text] [Related]
20. Restoration of euthyroidism does not improve cardiovascular risk factors in patients with subclinical hypothyroidism in the short term.
Beyhan Z; Ertürk K; Uçkaya G; Bolu E; Yaman H; Kutlu M
J Endocrinol Invest; 2006 Jun; 29(6):505-10. PubMed ID: 16840827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
